e-learning
resources
Monograph
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New antibiotic development for pulmonary infections: New Drugs for Bad Bugs and beyond
Tomislav Kostyanev, Marc J.M. Bonten, Herman Goossens
Source:
Eur Respir Monogr 2017; 75: 289-301
Journal Issue:
Anti-infectives and the Lung
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Tomislav Kostyanev, Marc J.M. Bonten, Herman Goossens. New antibiotic development for pulmonary infections: New Drugs for Bad Bugs and beyond. Eur Respir Monogr 2017; 75: 289-301
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
Eosinophils and airway nerves in asthma
Related content which might interest you:
Management of drug resistant pulmonary TB. New problems and perspectives
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009
New and repurposed drugs
Source: Eur Respir Monogr 2018; 82: 179-204
Year: 2018
Management of COVID-19: Drugs anti-virals
Source: ERS Course 2021 - COVID-19: State of the art
Year: 2021
New technologies of corrections hemithorax in treatment of pulmonary tuberculosis
Source: International Congress 2016 – Open problems in thoracic surgery
Year: 2016
New horizons in ventilator development
Source: ERS Course 2018 - Noninvasive ventilation: advanced
Year: 2018
Research in respiratory medicine: New approaches in genetic diseases
Source: ERS Summit on priorities in respiratory medicine 2011
Year: 2011
New Drugs for COPD: the current status
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
New anti-tuberculosis drugs for special populations: a difficult-to-address issue
Source: Eur Respir J 2016; 48: 957-958
Year: 2016
New frontiers in the management of asthma
Source: International Congress 2017 – State of the art session: "Paediatric"
Year: 2017
Prospects for new compounds tiosemikarbazonami class to create drugs with antituberculosis activity
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
New targets for drug development in asthma
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008
New and repurposed drugs for MDR-TB patients
Source: International Congress 2017 – PG2 Multidrug-resistant tuberculosis management in settings with a low tuberculosis incidence
Year: 2017
Phenotypes of symptomatic airways disease in China and New Zealand
Source: Eur Respir J, 50 (6) 1700957; 10.1183/13993003.00957-2017
Year: 2017
New definition of pulmonary rehabilitation
Source: Annual Congress 2012 - The updated ATS/ERS statement on pulmonary rehabilitation - update from the ATS/ERS Task Force
Year: 2012
New horizons in bronchiectasis
Source: International Congress 2017 – Bronchiectasis: from guidelines to real life
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept